PUBLISHER: iData Research Inc. | PRODUCT CODE: 1667642
PUBLISHER: iData Research Inc. | PRODUCT CODE: 1667642
The global men's reproductive health device market was valued at over $289 million in 2024 and is projected to grow at a CAGR of 2.5%, reaching over $343 million by 2031.
Market Segments Covered:
Comprehensive Market Insights
Global Market Trends
Market Share Insights
Top Competitors in the Global Erectile Dysfunction Device Market (2024):
1 Boston Scientific
* Market leader offering the AMS 700(TM) MS Series (three-piece inflatable devices) and AMS Ambicor(R) (two-piece inflatable devices).
* Dominates the market following its 2018 acquisition of American Medical Systems (AMS).
2 Coloplast
* Second-largest competitor with the Titan(R) Inflatable Penile Prosthesis and Malleable Penile Prostheses.
3 Rigicon
* Newest entrant offering the Rigi10(TM) (malleable prosthesis) and Infla10(R) (inflatable prosthesis).
Market Segmentation Summary
Global Research Scope
Report Details:
* North America: U.S., Canada
* Latin America: Brazil, Mexico, Argentina, etc.
* Western Europe: U.K., Germany, France, Spain, Italy, etc.
* Central & Eastern Europe: Russia, Poland, Turkey, etc.
* Middle East: Saudi Arabia, UAE, Israel, etc.
* Asia Pacific: China, Japan, India, Australia, etc.
* Africa: South Africa, Nigeria, Egypt, etc.
Quantitative Coverage:
Qualitative Coverage:
Data Sources:
Table of Contents
Men's reproductive health Device Market
List of Charts
List of Figures